TECH TRANSFER BENCHMARKING



Similar documents
The Role of Research Institutions in the Formation of the Biotech Cluster in Massachusetts

1. I appreciate the opportunity to make remarks to the UC Regents today.

Opportunities and Challenges in Technology Transfer and Start Up Creation in a Research University Rick McCullough Vice President for Research

Providing High-Quality Innovation and Technology Support Services University Experience and Best Practices. Professor Stanley Kowalski

University technology transfer through Innovation Incubator: A Case Study

What the Public Sector Should Know about Venture Capital

Fintech CIOs as venture capitalists

Technology Transfer at Stanford University

Seed Funding and Venture Capital Course Certificate Program. Greg Horowitt, Managing Director, T2 Venture Capital Kauffman Fellow, Class XV

Promoting hi-tech entrepreneurship through university -based technology incubatorssome thoughts coming from experience

Competitive Pay Policy

Keys To IP Collaborations With Universities: Part 3

VENTURE CAPITAL 101 I. WHAT IS VENTURE CAPITAL?

Invention and IP Creation Done with Speed, Quality and Relevance will Swing the Patent Pendulum in a Positive Direction


Financing your business. Dr. T. R. Heidrick Poole Professor in Technology Management Faculty of Engineering/School of Business U of A

University of Minnesota Start-up Guide

What is an Innovation Ecosystem? By Deborah J. Jackson. National Science Foundation, Arlington, VA

trainer course on IPR support for the internationalization of innovative biotech SMEs.

Venture Funding for the University Startup

Education. Lawrence Henze Elizabeth Crabtree. March 1, 2011

Angel Investors. in Groups. Returns to. November Robert Wiltbank, Ph.D. Willamette University

Five Ways Retailers Can Profit from Customer Intelligence

BENCHMARKING OF BUSINESS INCUBATORS. in the Republic of Moldova. Aurelia Braguta

Financing for innovative development

TECH COAST ANGELS BACKGROUND

Biotech funding surges

A Fund of Funds Investment Strategy to Create an Enduring Venture Capital Ecosystem in Wisconsin: Money for Minnows

Innovate Northeast Florida Economic Development Strategic Plan: Targeting Jobs and Talent for the Future Prepared for the JAXUSA Partnership By

The Biotech Business Life Cycle. The Lawyer s Role as Counselor and Advisor

Dollars For Genes: Revenue Generation by the California Institute for Regenerative Medicine

NZVIF Portfolio Investment Snapshots

Financial applications for brand valuation

About Our Private Investment Benchmarks

An Incubator As A Catalyst For High Tech Economic Development

Mahendra Jain

The ABCs of Venture Capital A Primer from the National Venture Capital Association

Capital Market Glossary of Terms Apple Capital Group, Inc

Russia USA Science to Innovations Accelerator (RUSSIA) Business Development and Training Program a at Arizona State University

I N N O V A T I O N R E S O U R C E S

Technology Commercialization and Startup Primer. Office of Technology Licensing (OTL) and UF Tech Connect Where Science Meets Business

UNIVERSITY TECHNOLOGY. LES TURKEY CONFERENCE 2010 ISTANBUL Omer Hızıroğlu

A PRACTICAL GUIDE TO VENTURE CAPITAL FUNDING FOR EARLY STAGE COMPANIES

Business Angels - an alternative source of financing innovative SMEs

source of financing innovative SMEs

Raising innovators as a major task of leading universities

Understanding Valuation: A Venture Investor s Perspective

B2B Marketing Trends: The Nativo Platform

OFFICE OF ENTREPRENEURIAL AFFAIRS AND TECHNOLOGY COMMERCIALIZATION

Open Innovation: An Imperative for the Pharmaceutical Industry. Berkeley Innovation Forum

Licensing Boot Camp: Intellectual Property & the Business of Biotech

Intellectual Property & Technology Commercialization Basics

Transforming relationships Unleashing innovation

Career Services. Venture Capital. Introduction. Venture Capital and Private Equity Overview. Career Path:

Entrepreneurial Opportunities for Georgia Tech Students

Agenda Item 4. Economic Development and Technology Commercialization Monograph

MID-TERM RAPIDE POLICY RECOMMENDATIONS SUMMARY

New Venture Creation at SAP Corporate Venturing In European Multinationals class Stanford University

The Role of Intermediaries Intermediary Management in the University

LA: THE DREAM STARTS HERE BUILDING LOS ANGELES INTO A GLOBAL CAPITAL OF CLEAN TECHNOLOGY

Business Model Designing the 9 blocks

Basic Economic Development Strategies

Executive Summary. Principal Findings

FORMULA FOR ILLINOIS FUTURE IN BIOSCIENCE ILLINOIS SCIENCE + TECHNOLOGY PARK. EXECUTIVE SUMMARY ADDENDUM February 2006

Roundtable: Medtech Funding and Investment

Technology Transfer Management Key Factors of Success. Elena Andonova, MBA September 14 th, 2015, Budapest, Hungary

7 Tips for Resonating With Millennial Employees & Their Desire to Do Good. By Kaitlin Carpenter, Carousel30 and Sarah Ford, America s Charities

State of the Market. Location Powered Mobile Advertising Report 2012 Annual Review. Volume 1

TECHNOLOGY TRANSFER STRATEGIC PLAN. The University of Montana

Richard Florida and James Spaniolo: North Texas is stronger together

Beyond Venture Capital: An Innovative Approach for Investment in New Ventures and Projects

Startup Employee Stock Options Plans (ESOPs) Overview and Best Practices

STARTUP CAPITAL VENTURES. Angel & Venture Capital Market 2015

Intangible Asset Valuation

Pharmaceutical Report Royalty Purchasing Industry. Thomas R. Wells

Marketing Science Institute Research Priorities

Finding Talent: Site Selection Labor Market Considerations for the Life Sciences Industry

Innovation Benchmarking Survey: New Findings on University Industry Relations and a UK Cambridge Policy Perspective

University Technology Transfer - Models, Components and Frameworks

Request for Information National Network for Manufacturing Innovation (NNMI)

A Texas Life Science Perspective. Thomas R. Kowalski President Texas Healthcare and Bioscience Institute

In recent years conversations among development

Guide to Public and Private Funding

Entrepreneurship and Innovation: MIT History and Observations. José J. Estabil Director, Program for Entrepreneurial Innovation

Approaches to tackle the research-business gap Technology audit principles. Practical support mechanisms

Leveraging Private Equity With Government Business Incentive Programs

Ohio Third Frontier Technology Validation and Start-Up Fund

The E-Learning Program of The Vocational Training Center of the National and Kapodistrian University uses innovative educational tools, such as:

Networking - A Case Study in Successful Business

Entrepreneurs Wary of Dilution? A Perspective to Consider

GREE International Inc. and Jobvite Play the Recruiting Game To Win

Financing a New Venture

INSTITUTIONAL TRADING PLATFORM

American Muslim Entrepreneurs

Entrepreneurship Education at European Universities and Business Schools Results of a Joint Pilot Survey

matching emerging technology and industry partners introduction to seedsprint for early-stage companies

Choosing the Ideal Structure for your Business Entity and Venture Capital Investment in 2010

PROSPER: MOMENTUM IS BUILDING

State of US Salaries Report

Valuation of Your Early Drug Candidate. By Linda Pullan, Ph.D. Toll-free USA Worldwide

Transcription:

TECH TRANSFER BENCHMARKING Alan Thomas Director, Office of Technology & Intellectual Property, The University of Chicago Extracted from an internal whitepaper written July 2007. With the aid of data from licensing surveys taken by the Association of University Technology Managers (AUTM), we can offer the following (perhaps idiosyncratic, but hopefully fair) observations on the game of university technology transfer. The central operational value chain in technology transfer is the transformation of research into invention disclosures, invention disclosures into patents, patents into licenses, and licenses into dollars, i.e.: Research Disclosures Patents Licenses Dollars It typically takes between $1.5m and $3m of basic research to generate one invention disclosure (closer to $3m historically at the University of Chicago). There is tremendous fallout along the value chain. Perhaps half of the disclosures will be transformed into patents, 15% of the original disclosures (once patented) will be licensed for development and commercialization. Only a fraction of these licenses will make any money, especially beyond their initial upfront payment. And a very small fraction of these licenses (1 or 2% of the licenses, 0.1 or 0.2% of the disclosures) will meet with commercial success sufficient to generate six to seven figure royalties to the university. Almost every university licensing program has one or two licenses constituting most of its income. Generally more than 99% of the value typically turns out eventually to come from less than 1% of the technology.

Typical Value Chain Normalized for 1000 Disclosures 1000 1000 Disclosures avg. $3MM research per 500 150 Licenses LOG SCALE 800 100 600 400 500 New Patent Applications ~50% of disclosures 10 0 15 Startups 10 VC Funded 6 Long-Term Businesses 1-2 Major Liquidity Events 200 150 Licenses 30% of Applications 2 Licenses generate $1MM+ ($20-$40MM in product sales) 0 15 Startups Sources: AUTM Surveys UCTech History Perhaps 10% of university licenses go to start-ups, of which perhaps two thirds will get funded, and 10-20% of these will generate major value in the form of liquidity events (IPO s or acquisitions). This can generate income from sales of stock independent of royalty income. Any way it s looked at, university tech transfer is truly panning for gold, even among its best practitioners. Because of the early stage nature of university technology, there is typically a lag of between five and 15 years between the time a disclosure is received and the time such a technology (if ever) meets success in the marketplace sufficient that it brings in significant royalties. Thus: - a 15-20 year time period to break even is typical and to be expected; - in the paradigm of the graph above, the time it will take an institution to accumulate 1000 disclosures will be highly dependent on its research base; - tech transfer financial performance tends to pop to a different level, like popcorn, when eventually a big winner arrives - big winners are driven disproportionately by royalties from pharmaceuticals (e.g. Taxol at Florida State, Remicade at NYU) or broadly adopted biotech tools (e.g. recombinant DNA at Stanford, cotransformation at Columbia). Although there is noise in the data (to some extent due to the popcorn effect ), tech transfer office performance broadly correlates with: - the quantity of research activity (more bets increase likelihood of success) - the quality of research activity (seminal work has more potential for impact) - tech transfer office age (a proxy for cumulative experience, time to accumulate big winners, and a networking effect related presumably to a lowering of transaction costs because of trust built up with business partners) - research flavor (basic vs. applied, presence of engineering school or medicinal chemistry capability)

- geography (metrics are better in dense technology clusters) - investment in tech transfer offices Tech transfer is generally accepted to have five missions arrayed along the spectrum of public to private interest: 1) public benefit, 2) economic development, 3) faculty service and reward for inventive activity, 4) industry interaction, and 5) revenue generation. In practice, the drop-out rates and time lags discussed above means that almost all the revenue, all the public benefit, and all the economic development stem from a small number of deals, generally many years after they were done. Meanwhile, much of the daily bread and butter of a technology transfer office relates to handling incoming disclosures, patent prosecution and maintenance, and licensee relationship management, all involving intensive interaction with a broad swathe of faculty. Technology transfer offices generally thus live and die by the word about them on the lab corridor. The long term health of the pipeline of technologies depends primarily on the relationship with faculty and the faculty s belief that the TTO is competent and acting in their best interests (i.e., on mission #3). Faculty inventors typically fall in to one of five categories: 1) will never invent (due to nature of work or philosophical disposition, 2) potential inventor, 3) occasional inventor, 4) repeat inventor, 5) serial inventor. It is rare that a single technology or patent supports a new product or market. Value tends to stem from large portfolios accumulated over many years millions of dollars of research. Likewise inventing is an activity with dramatic yields to experience. So the most money is or is likely to be made from serial inventors. The task of a technology transfer office, as a creative agent for faculty, is to identify potential inventors, encourage them to become occasional inventors, and if appropriate for the individuals and their field of study, lay out the resources to help them become repeat and serial inventors. There is thus a parallel demographic value chain: Potentials Occasionals Repeats Serials. Part of the challenge of managing a tech transfer activity is the tension between the reality that economic success is largely driven through a small proportion of the inventing individuals, and the egalitarian nature of a university, particularly The University of Chicago, where everyone is entitled to good service, every serial inventor starts somewhere, and word about the tech transfer office in the lab corridor has significant influence. An emphasis on start-ups, for instance, pushes the pendulum in the favor of the few elite, a political dynamic that needs to be managed if broad trust in the function is to be maintained. We ve estimated start-ups form around approximately 1.5% of the intellectual property coming out of universities. Yet their dynamics have a disproportionate ability to involve and attract academic rock-stars, engage large numbers of the university community including faculty, graduate students, alumni, trustees and visiting committee members, bring venture capitalists to a region, create jobs, attract investment, engage local politicians, enrich research interactions, bring big riches if successful, and generally influence the gestalt. Everyone can feel like a winner from big success stories

We analyzed conversion rates of basic research dollars into start-ups using AUTM data from 2002 to 2006. Although subject to some qualifications, we found a 10-fold difference in conversion rates between the most effective and least effective practitioners of the art, i.e. a range between $30m to $300m of basic research required to create each start-up. We divided the universities in the sample into deciles. The green bars show the four-year average of number of start-ups per year in each decile, and the blue line indicates the research funding required to generate each start-up. By this analysis the University of Chicago is in the 5 th decile. This is a potential benchmark of our start-up productivity. Average Number of Startups per Decile 50 40 30 20 10 Startup Activity & Research Funding Number of Startups Avg. Research $ per Startup 350 280 210 140 70 Research Funding per Startup ($MM) - 1 2 3 4 5 6 7 8 9 10 Startup Efficiency Decile 0 DECILES START-UP EFFICENCY BENCHMARKING What drives differences in start-up efficiency? Start-ups require work, of two kinds and highly coupled. The first is knowledge work : recognizing opportunity and creating and refining a credible story that will attract the necessary resources. The second is actually recruiting the

necessary resources: intellectual property, money, management, equipment, space. A fundable start-up might require between 1000 and 2000 hours to create. Start-up efficiency is driven by the transaction costs involved in such activities. These often have a strong geographical dependence. As regional eco-system builds up, transaction costs fall. Eco-system can be deconstructed as another value chain: At source: - a reliable flow of innovations stemming from a strong research base (>$500m) - tech transfer supportive of start-ups; strong, secure, and well-regarded in its institution and region, not protective of access to faculty For incubation: - mechanisms for networking that allow the top academic inventing talent and the top entrepreneurial management to find each other - ready availability of early stage venture management talent and appropriate space in which early stage venture can locate themselves - proof-of-concept funding, whether as university or quasi-university dedicated bridge funds, angel funds, or seed stage venture funds For growth: - later stage venture funding - available and appropriate facilities to expand into - a ready pool of qualified labor to recruit and specialist suppliers of services As with other economic cluster phenomena, entrepreneurial eco-system operates according to the dynamics of critical mass. At about the level of 60 to 80 companies in a particular technology area (e.g. biotech, or IT, or instrumentation, or medical devices) in a particular region, technology cluster dynamics start to become self-reinforcing, and energy no longer has to put into the system to make it work. At this level a handful of the start-ups will statistically see significant success, involving a liquidation event that generates substantial wealth, and managers starting to spin out to do it again both as angels and entrepreneurs. Concentric circles of management generations grow. Shared background and known measures of track record pedigree lower transaction costs since shared experience generates trust. The perceived risk of investing in an early stage venture falls as it becomes easier to find high quality management, other funds to syndicate with, appropriate facilities etc. The perceived risk of being involved in a venture as entrepreneurial management falls as the ease of recycling to neighboring ventures increases. Cumulative regional experience leads to increasingly sophisticated diligence capabilities for local investors. Entrepreneurial eco-system also operates according to the dynamics of critical density. Although regions tend to have reputations as technology clusters (San Francisco Bay Area, Cambridge MA, San Diego, Research Triangle), activity is actually clustered even locally in very particular zip codes (02139 in Cambridge, Longwood Medical Campus in Boston, Sand Hill Road in Palo Alto, Torrey Pines Road in San Diego). It is difficult to name a well-known technology cluster in a major metropolitan area. New York, Los Angeles, and Chicago for instance have major challenges of dispersed research, distance, traffic, and parking.

Clusters tend to contain a high degree of collaboration (as opposed to competition), among the various interested organizations in town. The competition for donors, local government funding, networking forums, entrepreneurial talent, companies to populate incubators etc. is not regarded as a zero sum game. Much of the leverage and conversion efficiency of the high-functioning clusters come from the fact that the tech transfer office is no longer doing most of the heavy lifting in terms of sourcing deals, trying to fund early proof-of-concept and building the business cases. The tech transfer offices ultimately are not the progenitors of most of the deals being struck, merely a waypoint and facilitator. The lab corridors are metaphorically crawling with entrepreneurs and venture capitalists already doing this work. Alternatively, for other institutions with a high efficiency of start-up creation, their region is committed enough to throw several million dollars a year at trying to create the elements of eco-system.